Back to News
Market Impact: 0.25

RFK Jr.  is pushing Americans to eat more red meat and dairy as Starbucks, Chipotle, and others cash in on protein craze

SBUX
Consumer Demand & RetailProduct LaunchesRegulation & LegislationHealthcare & BiotechCommodities & Raw MaterialsInvestor Sentiment & Positioning

The HHS released new U.S. nutrition guidelines advocating 1.2–1.6 g of protein per kg of body weight (about 126 g/day for men and 109 g/day for women), a marked increase from prior guidance and a departure in part toward more red meat consumption. Major food chains including Starbucks, Chipotle and Dunkin are rolling out high-protein products to capture rising consumer demand—driven in part by GLP-1 drug usage—while health flags persist: WHO recommends 0.8 g/kg, average U.S. adults consumed ~81 g/day in 2020, and Consumer Reports found heavy metals in some protein drinks. The shift creates a modest investment theme for food retailers, protein suppliers and meat markets, but regulatory scrutiny and health risks temper upside for long-duration bets.

Analysis

Market structure: Quick-service chains and packaged-protein suppliers are the near-term winners — SBUX should capture incremental AUV from protein beverages (estimate +0.5-1.5% comps over 1–3 quarters if uptake mirrors rollout). Protein commodity beneficiaries include beef and poultry processors (TSN, HRL) and ingredient suppliers (ADM) if consumer uptake shifts 5–15% of snack calories to protein over 12–24 months. Incumbent snack/sugar-heavy brands (KHC, MDLZ) face demand risk and potential margin pressure as consumers trade down sugary SKUs. Risk assessment: Tail risks include a regulatory backlash (FTC/FDA advertising limits or WHO-guided policy) or a Consumer Reports–style contamination scare that could trigger recalls and a >30% re-rating in specialty protein drink names within 30–90 days. Short-term (days–weeks) effects are promotional-driven sales spikes; medium-term (3–12 months) depends on GLP‑1 penetration and menu adoption; long-term (1–3 years) hinges on persistent behavior change—full adoption would require raising average protein intake from 81g to ~110–125g/day (a ~35–55% increase), which is unlikely. Trade implications: Tactical longs: SBUX (small overweight 1–2% notional) and select processors (TSN, HRL) for 6–12 months; tactical shorts: packaged-sugary snack incumbents (KHC) on potential share loss. Use pair trades: long TSN vs short KHC for relative exposure to protein vs sugar. Options: buy 3–6 month SBUX call spreads (5–10% OTM) sized to 0.5–1% portfolio to cap risk while capturing rollout upside. Contrarian angles: Consensus overstates sustainable incremental demand — GLP‑1 adoption reduces total calories, capping protein upsizing; heavy‑metal and saturated‑fat concerns could shift premium to whole-food proteins (benefiting processors) and away from powdered drinks (risking sharp de-rating). Historical parallel: the early 2000s low‑carb surge saw a 12–18 month revenue bump then normalization; expect similar mean reversion unless regulatory endorsement becomes entrenched. Unintended consequence: persistent red‑meat lift could push feed-grain prices +5–15% in 12–18 months, pressuring COGS for both meat processors and other food producers.